SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
Clinical trial NCT06476093 · RECRUITING
Trial details
- NCT number
- NCT06476093
- Sponsor
- The First People's Hospital of Lianyungang
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-12-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.